CASP3 and cervical cancer: The caspase-3 activity (Figure 5(c)), TUNEL-positive nuclei percentage (Figure 5(d)), and Annexin V-positive staining (Figure 5(e)) were all significantly enhanced in TN-treated primary human cervical cancer cells.